The shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) started off the last trading session with the price of $19.53 while closing the day with the price of $19.9. The shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) Rise 0.45% with the Gain of 0.37 points.
The shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) traded with the day volume of 1.04 Million shares whereas its average trading volume is 1.22 Million.
While analyzing the past performance of the stock we can see that the shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) Gain 0.15% in the last week while rising 6.53% in the last month. Past quarter performance shows the green light with 7.1%. The semi-annual and annual performance shows 56.2% and 48.95% respectively.
Some critical values of the shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) to be discussed here are: the beta which shows the value at 1.89 while Average True Range of Halozyme Therapeutics, Inc. (NASDAQ:HALO) demonstrate the value at 0.81. The weekly and monthly volatility of the shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) are indicated at 3.30% and 4.65%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 58.27.
While studying the financial position of the shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO), we can see that the Market capitalization of the company is at 2.83 Billion. The shares outstanding for the company is 142.43 Million and the shares float stands at 123.99 Million. The income of the company stand at 80.1 Million while the sales stand at 316.6 Million.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.46, Price to Earnings or P/E is at 43.36, Price to Sales P/S show the value of 8.95, the Return on Asset ROA stood at 0.174 and the Return on Equity ROE depicted at 0.898 while Return on Investment ROI is at 0.242.
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX)
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) started its previous trading session at $4.48 and closed at $4.74 showing a Rise of 5.1 Percent.
The Company traded with an average Volume of 1.44 Million whereas, its Day Volume stood at 1.04 Million.
Looking at the performance of the stock, Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) Loss -6.69% in the last week in its shares price and 2.38% in the last month. Quarterly performance shows a green of 1.94 Percent while Semi-Annual and Annual performances shows a -34.53 and -1.04 percent respectively.
Beta for Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) stands at 2.58 while the ATR (average true range) is at 0.25. The Stock’s Weekly and Monthly Volatility is 5.29% and 5.68% respectively showing a RSI value of 49.61.
While studying the financial position of the shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), we can see that the Market capitalization of the company is at 565.22 Million. The shares outstanding for the company is 119.25 Million and the shares float stands at 117.6 Million.
The Company generated an income of -275100000 and the sales of 60.6 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-2.37 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 9.33 respectively.
The Return on Assets stands at -1.014, ROE shows a value of 0 and ROI for Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) is -1.901 as of Trailing Twelve Months period.
